L-749-329

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameL-749-329
Drug Alias NameL-749,329L-749329L-749-329
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronary Restenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co
Active IndicationsN/A
Inactive IndicationsCoronary Restenosis

Other Information

ATC CodeN/A
Related LinksN/A